Limfoma folikular Dokter Terbaik di Israel - TOP-21 dokter

Dr. Ram Ron adalah Associate Professor dan spesialis senior di bidang hemato-onkologi dan transplantasi sumsum tulang di Tel Aviv Sourasky Medical Center.

• Lebih dari 25 tahun pengalaman klinis dan akademik khusus
• Associate Professor di Tel Aviv University – melatih calon spesialis
• Berfokus pada limfoma, leukemia, dan mieloma sebagai ahli hematologi
• Ahli dalam kemoterapi dosis tinggi dan transplantasi sumsum tulang untuk kanker darah
• Menerbitkan lebih dari 90 artikel penelitian di jurnal medis terkemuka

Telah melakukan beberapa ratus transplantasi sel induk, pengobatan utama untuk limfoma folikular, di Sourasky Medical Center (Ichilov).

• Tersertifikasi dalam bidang hematologi, onkologi, dan penyakit dalam
• Menulis lebih dari 30 artikel ilmiah dan satu bab buku teks
• Menyelesaikan fellowship spesialis hematologi dan onkologi di New York
• Memberikan kontribusi akademik yang luas di bidang medis

Dr. Ronit El Hasid adalah spesialis pediatrik terkemuka yang telah melakukan lebih dari 300 transplantasi sumsum tulang dan darah tali pusat di Rumah Sakit Anak Dana Dwek.

• Kepala Departemen Onkohematologi dan Onkologi Pediatrik
• Spesialisasi dalam transplantasi untuk anak-anak dengan kanker darah dan kelainan darah
• Anggota American Society of Hematology
• Anggota Israeli Society for Pediatric Hematooncology
• Pelatihan di City of Hope Hospital yang bergengsi di Los Angeles

Prof. Amos Toren, MD, PhD, MHA, is a pediatric hemato-oncologist and BMT specialist. He served as Director of Pediatric Hemato-Oncology and BMT at Sheba Medical Center.

He is board certified in Pediatrics, Pediatric Hemato-Oncology, and Bone Marrow Transplantation. He holds a PhD in Human Genetics. He was Head of the Hematology Division at Tel Aviv University for two terms. He is a member of ASH, COG, ESPHI, EBMT, and CIBMTR. He also serves on the Ministry of Health Cord Blood Committee.

He led one of Israel’s most advanced pediatric oncology and BMT programs. The program treated children and young adults. His focus includes leukemia and lymphoma, immunodeficiencies, and rare cancers. He specializes in BMT and CAR T-cell therapy.

His translational research covers CAR T cells, cytokine-induced killer cells, pediatric brain tumors, and targeted therapies. He has worked with St. Anna, the NIH, and St. Jude. His publications include studies on pediatric SCT prophylaxis and PARP resistance.

Dr. Hana Golan, MD, heads the Pediatric Hemato-Oncology and Bone Marrow Transplantation (BMT) Division at Sheba Medical Center. She specializes in childhood cancers, with a focus on neuroblastoma and other high-risk solid tumors.

She leads one of the region’s most advanced pediatric oncology programs. She manages complex, high-risk cases and practices at a hospital ranked in the global top 10.

She is the principal investigator of the High-Risk Neuroblastoma ESIOP protocol. She serves as an investigator in international Phase I/II trials and as the national coordinator of multicenter oncology protocols. She led the development of computerized chemotherapy protocols and patient databases to improve safety.

She earned her MD from the Technion. She completed residencies in pediatrics and pediatric hemato-oncology at Sheba. She conducted advanced research in transplantation immunology at the Weizmann Institute. She is board-certified in Pediatrics and Pediatric Hematology-Oncology. She is a Senior Lecturer at the Sackler Faculty of Medicine, Tel Aviv University. Her research focuses on cancer stem cells, targeted therapies, treatment-resistant malignancies, and cannabinoid-related oncology.

Dr. Michael Shapira adalah spesialis dalam Transplantasi Sumsum Tulang di Sourasky Medical Center (Ichilov), dengan pelatihan ekstensif di institusi terkemuka.

• Lulus dari Fakultas Kedokteran Hebrew University
• Spesialisasi dalam penyakit dalam di Hadassah Medical Center
• Dokter senior dalam Transplantasi Sumsum Tulang di Hadassah
• Fasih berbahasa Inggris dan Ibrani untuk komunikasi yang jelas

Dr. Fredi Aviv memiliki pengalaman selama 31 tahun dalam menangani kanker hematologi di salah satu rumah sakit terkemuka di Israel – Sourasky Medical Center (Ichilov).

• Onkohematolog bersertifikat, spesialisasi dalam kanker darah dan sistem limfatik.
• Menghabiskan seluruh kariernya bekerja di Sourasky Medical Center.
• Fokus mendalam pada perawatan kanker dewasa di lingkungan rumah sakit universitas utama.

Dr. Levin adalah direktur departemen hematologi onkologi pediatrik di Sourasky Medical Center di Tel Aviv, yang berfokus pada gangguan darah dan kanker anak.

• Mengoordinasikan pengobatan kanker tulang (sarkoma) pada anak-anak dengan departemen Onkologi-ortopedi
• Berspesialisasi dalam hematologi dan onkologi pediatrik, dilatih di Schneider Children's Medical Center
• Anggota Israel Society of Pediatric Hematology Oncology (ISPHO)
• Mempelajari onkologi di Rizzoli Orthopaedic Institute di Bologna – pusat terkemuka di dunia

Dr. Kirshner aktif terlibat dalam uji klinis mutakhir, termasuk pengujian perawatan baru untuk kanker yang resistan di Sourasky Medical Center.

• Pelatihan fellowship ganda dalam hematologi dan onkologi medis
• Pengalaman lebih dari 25 tahun mengobati kanker darah
• Berpartisipasi dalam uji klinis fase III untuk terapi lanjutan
• Spesialisasi dalam kasus limfoma folikular yang resistan terhadap pengobatan

Ahli hematologi pemenang banyak penghargaan yang berspesialisasi dalam leukemia limfositik kronis – Dr. Herishanu Yair menghadirkan keahlian berbasis penelitian untuk perawatan pasien di Sourasky Medical Center.

• Pengalaman lebih dari 15 tahun di bidang hematologi
• Penerima hibah bergengsi dari Israeli Science Foundation dan Weizmann Institute
• Anggota Asosiasi Hematologi Israel dan Amerika
• Menempuh pendidikan di institusi medis terkemuka di Israel
• Peneliti yang mempublikasikan karya di bidang hematologi

Dr. Hila Magen, MD, leads the Multiple Myeloma and Amyloidosis Unit at Sheba Medical Center. She is a hemato-oncologist with over 35 years of experience. She is a leading Israeli expert in multiple myeloma and plasma cell disorders.

She runs a program that provides personalized care and early access to clinical trials. This includes CAR-T therapy for high-risk and relapsed or refractory myeloma and amyloidosis. Dr. Magen is a principal investigator in point-of-care CAR-T studies. She brings new immunotherapies into routine care.

Training: Fellowships in Multiple Myeloma (UAMS) and Lymphocytic Leukemia (MD Anderson). Academic: Instructor, Tel Aviv University. Research: Author of 100+ publications, contributor to landmark myeloma studies, and reviewer for international journals.

Prof. Avichai Shimoni, MD, is Director of Bone Marrow Transplantation at Sheba Medical Center. He is a hemato-oncologist with over 30 years of experience in bone marrow transplantation, cellular therapies, and advanced blood cancer care.

He leads a high-volume program for complex, high-risk blood cancers. He performs allogeneic and autologous transplants. He also provides CAR T-cell therapy for leukemia, lymphoma, and multiple myeloma. He completed a bone marrow transplantation fellowship at MD Anderson Cancer Center.

He is Chairman of Hematology at Tel Aviv University and a Professor of Hematology. He has authored more than 250 scientific papers. His research focuses on CAR T-cell therapy and stem cell transplantation. He is often listed among Israel's Best Doctors (Forbes 2025 and 2026).

Seorang profesor yang berspesialisasi dalam hematologi dan transplantasi sumsum tulang – Prof. Zuckerman menerapkan keahlian akademik yang mendalam untuk merawat pasien di Rambam Medical Center.

• Berfokus pada kanker hematologi dan onkologi transplantasi
• Memimpin unit spesialis hematologi dan transplantologi
• Profesor akademik – pemimpin dalam penelitian dan pendidikan medis
• Bagian dari pusat kanker multidisiplin terkemuka di Israel

Dr. Iris Kventsel, MD, is a pediatric hemato-oncologist and bone marrow transplant (BMT) specialist at Sheba Medical Center. She is an attending physician in the Pediatric Hemato-Oncology and BMT Division at the Edmond and Lily Safra Children’s Hospital. Her clinical focus is pediatric sarcomas, including Ewing sarcoma, osteosarcoma, and rhabdomyosarcoma.

She provides multidisciplinary care, including transplant and cellular therapies. She also uses current chemotherapy protocols and targeted therapies for complex childhood cancers.

Her research focuses on genetic cancer predisposition, including Li-Fraumeni syndrome, and cancer susceptibility genes. She has published in pediatric oncology, stem cell biology, and surgical oncology (HIPEC). She is on the academic staff at Tel Aviv University. Education: MD, Technion; Pediatrics residency, Assaf HaRofeh; Pediatric Hemato-Oncology fellowship, Sheba.

Dr. Ofer Spielberg adalah seorang onkohematolog berdedikasi di Assuta Medical Center yang berspesialisasi dalam kanker darah seperti limfoma folikular.

• Fokus secara eksklusif pada diagnosis dan pengobatan keganasan hematologi
• Menjadi bagian dari departemen onkologi terkemuka di Israel
• Memiliki keahlian dalam protokol pengobatan modern untuk limfoma

Diakui oleh Forbes sebagai salah satu dokter terbaik pada tahun 2018 – Dr. Stepensky telah melakukan lebih dari 3.500 transplantasi sumsum tulang.

• 20 tahun pengalaman dalam hematologi anak
• Spesialisasi dalam mengobati kanker darah langka pada anak-anak
• Pasien dan keluarga menjulukinya sebagai 'sosok yang mentransplantasikan kehidupan'
• Bekerja di Hadassah Medical Center

Dr. Abraham Avigdor, MD, is Director of the Institute of Hematology and Co‑Director of the Hematology & Bone Marrow Transplantation Division at Sheba Medical Center. He is an international leader in lymphoma, CAR‑T, and advanced hemato‑oncology with more than 35 years of experience. His clinical focus includes lymphomas, multiple myeloma, and complex blood cancers.

He is a pioneer in CAR‑T integration. He leads cellular therapy and bone marrow transplantation programs (autologous and allogeneic). He also advances stem cell therapies and precision diagnostics, including PET/CT‑based prognostics. His work includes immunotherapy and targeted regimens and the development of innovative, data‑driven protocols.

He collaborates with LYSA, EMCL, and international PET groups. He has authored more than 130 publications. Key roles include Founder and President of the Israeli Lymphoma Working Group, former Chair of the Israeli Lymphoma Study Group, and Senior Lecturer at Tel Aviv University. Education: MD, Ben‑Gurion University; residency, Sheba Medical Center; postdoctoral fellowship, Weizmann Institute. Awards include the Knesset Prize, the Israeli Ministry of Health Award, and the Sackler Prize.

Prof. Elad Jacoby, MD, heads the Pediatric Cell Therapy Center at Sheba Medical Center. He is the Medical Director of the Advanced Biotherapy Center. He is a pioneer of pediatric CAR T‑cell therapy in Israel. He led one of the first national leukemia programs. He has almost 20 years of clinical and research experience.

He specializes in CAR T‑cell therapy, bone marrow and stem cell transplantation, and high‑risk pediatric leukemias and lymphomas. He leads international clinical trials and has authored over 240 publications. His collaborations include Johns Hopkins Hospital and the U.S. National Cancer Institute. He is an Associate Professor at Tel Aviv University. He received his MD from Tel Aviv University, completed residency at Sheba Medical Center, and fellowships at Johns Hopkins and the National Cancer Institute. He is board‑certified in Pediatrics and in Pediatric Hematology and Oncology. He serves on the IBFM CAR T‑Cell Taskforce and the Sheba Institutional Review Board. He leads the integration of CAR T‑cell therapy with transplantation.